Prevalence of Plasmid-Mediated Quinolone Resistance and Mutations in the Gyrase and Topoisomerase IV Genes in Salmonella Isolated from 12 Tertiary-Care Hospitals in Korea
- 1 December 2011
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 17 (4) , 551-557
Abstract
Background: The aim of this study was to investigate the prevalence of plasmid-mediated quinolone resistance (PMQR) and mutations in quinolone resistance-determining regions (QRDRs) of Salmonella and their association with fluoroquinolone susceptibility in Korea. Methods: A total of 284 nonduplicated clinical isolates of Salmonella were collected from various clinical specimens at 12 tertiary-care hospitals in Korea. The qnrA , qnrB , and qnrS genes were detected by multiplex polymerase chain reaction (PCR). The qepA and aac(6′)-Ib-cr genes were amplified by PCR. The QRDRs of gyrA , gyrB , parC , and parE were amplified by PCR from the DNA of selected nalidixic acid-resistant and qnr -positive isolates. Results: We detected six qnr -positive Salmonella (four qnrS1 and two qnrB19 ) and one aac(6′)-Ib-cr– positive strain. A mutation in the QRDR of gyrA only ( N =46) was the most common, followed by gyrA + parC ( N =9), parC ( N =7), gyrA + parE ( N =3), parC + parE ( N =3), gyrA + gyrB ( N =2), and parE ( N =1). There were seven novel mutations in the QRDR regions of gyrB , parC , and parE . Six of seven PMQR-positive isolates had high-level resistance to nalidixic acid, and all six strains had reduced susceptibility to ciprofloxacin. One qnrS1 -positive isolate was resistant to ciprofloxacin, norfloxacin, and nalidixic acid. The resistant rates to nalidixic acid, ciprofloxacin, norfloxacin, and levofloxacin were 49.3%, 1.1%, 0.7%, and 0.4%, respectively. Conclusion: We report the first detection of PMQR in Salmonella isolates from Korea. It is essential to continue surveillance and to watch for the spread of PMQR in Salmonella for public health control.Keywords
This publication has 28 references indexed in Scilit:
- Emergence of Plasmid-Mediated Quinolone Resistance among Non-Typhi Salmonella enterica Isolates from Humans in the United StatesAntimicrobial Agents and Chemotherapy, 2009
- Characterization of Salmonella enterica isolates from infants and toddlers in Wuhan, ChinaJournal of Antimicrobial Chemotherapy, 2008
- Plasmid-Mediated qepA Gene among Escherichia coli Clinical Isolates from JapanAntimicrobial Agents and Chemotherapy, 2008
- New Plasmid-Mediated Fluoroquinolone Efflux Pump, QepA, Found in an Escherichia coli Clinical IsolateAntimicrobial Agents and Chemotherapy, 2007
- Prevalence of qnr genes in Salmonella in FranceJournal of Antimicrobial Chemotherapy, 2007
- Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying EnzymeAntimicrobial Agents and Chemotherapy, 2006
- qnrB , Another Plasmid-Mediated Gene for Quinolone ResistanceAntimicrobial Agents and Chemotherapy, 2006
- Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistanceJournal of Antimicrobial Chemotherapy, 2005
- Mechanisms of quinolone resistance in SalmonellaVeterinary Research, 2001
- Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype TyphimuriumJournal of Medical Microbiology, 1997